| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/15/2004 | WO2004031373A1 Method of constructing differentiated cells |
| 04/15/2004 | WO2004031360A2 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 04/15/2004 | WO2004031359A2 Method for regulating expression genes |
| 04/15/2004 | WO2004031357A2 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 04/15/2004 | WO2004031353A2 Apparatus and method for streaming electroporation |
| 04/15/2004 | WO2004031351A2 Microarrays having multiple oligonucleotides in single array features |
| 04/15/2004 | WO2004031350A2 Modulation of forkhead box o1a expression |
| 04/15/2004 | WO2004031349A2 Polynucleotides and polypeptides in plants |
| 04/15/2004 | WO2004031242A2 Protein complexes involved in neurological diseases |
| 04/15/2004 | WO2004031237A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | WO2004031235A1 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 04/15/2004 | WO2004031234A2 Regulation of human calcium-independent alpha-latrotoxin receptor |
| 04/15/2004 | WO2004031233A2 Novel chemokine-like polypeptides |
| 04/15/2004 | WO2004031230A2 Novel mhc ii associated peptides |
| 04/15/2004 | WO2004031228A1 Protein made of penicillium olsonii, providing resistance against 2-deoxyglucose |
| 04/15/2004 | WO2004031227A1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 04/15/2004 | WO2004031225A1 Orthopoxvirus vectors, genes and products thereof |
| 04/15/2004 | WO2004031224A2 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | WO2004031222A2 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004031201A2 Systems and methods for selection and design of short interfering rna |
| 04/15/2004 | WO2004031142A2 Inhibition of metallo-beta-lactamase |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030750A1 Antisense modulation of farnesoid x receptor expression |
| 04/15/2004 | WO2004030699A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/15/2004 | WO2004030694A1 Bacteriophage-mediated immunisation against hepatitis |
| 04/15/2004 | WO2004030660A2 Compositions for treatment of prostate and other cancers |
| 04/15/2004 | WO2004030634A2 Therapeutic compositions |
| 04/15/2004 | WO2004030631A2 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | WO2004030630A2 Focal calcium channel modulation |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004018639A3 Male sterility restoration as a selectable marker in plant transformation |
| 04/15/2004 | WO2004009847A3 Functional screening method involving protein translocation/redistribution |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003209A3 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 04/15/2004 | WO2004003012A3 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/15/2004 | WO2004002215A8 Genetic manipulation of condensed tannins |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2003106638A3 Methods and cells for improved production of polyketides |
| 04/15/2004 | WO2003106488A3 Antagonists of cxr3-binding cxc chemokines |
| 04/15/2004 | WO2003104275A3 Genes and polypeptides relating to human colon cancers |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003103378A3 Fish produced by nuclear transfer from cultured cells |
| 04/15/2004 | WO2003099859A3 Novel use of adenoviruses and nucleic acids coding therefor |
| 04/15/2004 | WO2003094849A3 Ferritin fusion proteins for use in vaccines and other applications |
| 04/15/2004 | WO2003093505A3 Method for determining the presence of an unconventional transmissible agent responsible for transmissible subacute spongiform encephalopathy |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003089621A3 Promoter and plasmid system for genetic engineering |
| 04/15/2004 | WO2003089618A9 Transposon system and methods of use |
| 04/15/2004 | WO2003085134A3 Methods of diagnosing and treating colorectal cancer |
| 04/15/2004 | WO2003079883A3 Controlled laser treatment for non-invasive tissue alteration, treatment and diagnostics with minimal collateral damage |
| 04/15/2004 | WO2003078570A3 Multiple controls for molecular genetic analyses |
| 04/15/2004 | WO2003072602A3 Protein complexes and methods for their use |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003061591A3 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003054212A8 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 04/15/2004 | WO2003052119A3 Transporters and ion channels |
| 04/15/2004 | WO2003051309A3 Antisense modulation of abc transporter mhc 1 expression |
| 04/15/2004 | WO2003050250B1 Chondrocyte precursors derived from human embryonic stem cells |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003044163A3 Antisense modulation of toll-like receptor 4 expression |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | WO2003038044A3 DNA POLYMERASE ETA (POLη) CDNA AND USES THEREOF |
| 04/15/2004 | WO2003020767A9 Antibodies against caspase-8, their preparation and use |
| 04/15/2004 | WO2003018823A8 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 04/15/2004 | WO2003017825A3 Methods of treating obesity |
| 04/15/2004 | WO2003012062A9 Animal model with disrupted fgf14 gene |
| 04/15/2004 | WO2003008571A9 Chimeric chains that code for proteins that induce effects directed against viruses |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002756A9 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002102975A3 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 04/15/2004 | WO2002099079A3 Cytokinin response regulators and uses thereof |
| 04/15/2004 | WO2002090993A3 Functional protein expression for rapid cell-free phenotyping |
| 04/15/2004 | WO2002086094A3 Genes involved in isoprenoid compound production |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002064763A8 Novel human poly(a)polymerase gamma (pap gamma) |
| 04/15/2004 | WO2002063951A9 Human disease modeling using somatic gene transfer |
| 04/15/2004 | WO2002059330A8 Artificial chromosomes comprising concatemers of expressible nucleotide sequences |
| 04/15/2004 | WO2002059297A8 A library of a collection of cells |
| 04/15/2004 | WO2002059296A8 Concatemers of differentially expressed multiple genes |
| 04/15/2004 | WO2002059290A8 A method for evolving a cell having desired phenotype and envolved cells |
| 04/15/2004 | WO2002055721A3 Modular transfection systems based on nucleoprotein filaments |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002034953A3 Detection and quantification of human herpes viruses |
| 04/15/2004 | WO2002031157A8 Shrimp alkaline phosphatase |
| 04/15/2004 | WO2002024872A8 Manipulation of spermatozoa |
| 04/15/2004 | WO2002018424A9 Nucleic acids and polypeptides |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2001075049A3 A novel polypeptide - a human clathrin light chain 11 and the polynucleotide encoding the polypeptide |
| 04/15/2004 | WO2001070955A8 Identification of essential genes in prokaryotes |
| 04/15/2004 | US20040073977 Transgenic plants that are resistant to a broad spectrum of pathogens |
| 04/15/2004 | US20040073976 Comprises nucleotide sequences coding fructose 1,6 bisphosphate aldolase (FDA) for transformation and propagation in potato and to increase growth, development, yield, vigor, stress tolerance and starch distribution |
| 04/15/2004 | US20040073975 Transgenic corn expressing fructosyltransferase and biosynthesizing modified fructans for use in medicine, food and animal feeds |
| 04/15/2004 | US20040073974 Comprises nucleotide sequences coding cyclopropane synthetases for transformation and propagation in plants; improving functional stability and/or taste of plant oils |
| 04/15/2004 | US20040073972 Using luecine zipper domain protein to activate transcription from rice tungro bacilliform viral (RTBV) promoter; enhancing plant gene expression |
| 04/15/2004 | US20040073971 Sunflower anti-pathogenic proteins and genes and their uses |
| 04/15/2004 | US20040073970 Transgenic magnaporthe resistant rice; tissue engineering; horticulture |